Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-09-15FDA Approved: GLIMEPIRIDE — Supplemental Application (Micro Labs Limited)
FDA approves a supplemental application for glimepiride from Micro Labs Limited, authorizing a generic version of the diabetes medication.
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes [Phase 4]
A Phase 4 trial comparing metformin to sitagliptin for efficacy in patients with type 2 diabetes and benign thyroid nodules; current status …
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Vitamin D and Type 2 Diabetes Study [NA]
A completed clinical trial on vitamin D and its effects in prediabetes and type 2 diabetes, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: Impact of the Type of Reconstruction Methods on Diabetes Following Laparoscopic Distal Gastrectomy in Patients With Gastric Cancer and Type 2 Diabetes [Phase 2]
Phase 2 trial evaluating how reconstruction method after laparoscopic distal gastrectomy affects diabetes status in patients with gastric ca…
-
FDA approval · 2020-09-03FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Trulicity (dulaglutide) filed by Eli Lilly and Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care [Phase 4]
Phase 4 trial update evaluating a comprehensive intervention for type 2 diabetes and comorbid depression in primary care.
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: The Effectiveness of Flash Glucose Monitoring System on Glycemic Control in Patients With New-onset Type 2 Diabetes [Phase 4]
Phase 4 trial assessing the effectiveness of a Flash Glucose Monitoring System on glycemic control in patients with new-onset type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Peer Support Dyads in Churches [NA]
A completed clinical trial evaluating peer support dyads in church settings for chronic disease management, including obesity, with results …
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: Text to Move (TTM)Study [Phase 2]
Phase 2 clinical trial update for Text to Move (TTM) in Type 2 Diabetes Mellitus completed.
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension [Phase 2]
Phase 2 trial of IW-1973, an sGC stimulator, in stable type 2 diabetes with hypertension completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy [Phase 2, Phase 3]
Phase 2/3 clinical trial exploring N-acetylcysteine (NAC) for ameliorating diabetes-induced nephropathy; current status unknown.
-
FDA approval · 2020-08-21FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for Bromocriptine Mesylate submitted by Padagis US LLC.
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy [Phase 2, Phase 3]
Clinical trial updates investigate the impact of non-surgical periodontal therapy on glycemic control in adults with chronic periodontitis a…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Tubular Markers in Response to Saxagliptin Therapy [Phase 4]
Phase 4 trial update examining tubular markers in response to saxagliptin therapy for type 2 diabetes.
-
FDA approval · 2020-08-18FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved Janssen's supplemental application for INVOKAMET (canagliflozin and metformin hydrochloride). This action approves a supplement…
-
FDA approval · 2020-08-18FDA Approved: INVOKAMET XR — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVOKAMET XR (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals to modify/…
-
FDA approval · 2020-08-18FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVOKANA (canagliflozin) from Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients [Phase 4]
Phase 4 trial evaluating a combination of acarbose, metformin, and sitagliptin in patients with type 2 diabetes mellitus has completed with …
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes [NA]
Clinical trial completed on improving medication adherence among underserved patients with Type 2 diabetes; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2) [Phase 3]
A Phase 3 non-inferiority trial comparing Mylan's insulin glargine to Lantus in Type 2 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Impact of Dapagliflozin on DIAstolic Dysfunction in Type 2 Diabetic Patients [Phase 4]
Phase 4 trial evaluating the impact of dapagliflozin on diastolic dysfunction in patients with type 2 diabetes mellitus. Completed.
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease [Phase 4]
Phase 4 trial evaluating the efficacy of pioglitazone hydrochloride and metformin hydrochloride tablets for patients with newly diagnosed ty…
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients [Phase 1, Phase 2]
A clinical trial update describes BM-MNC and UCMSC therapy for type 2 diabetes mellitus in Phase 1/2 studies; no results or status disclosed…
-
FDA approval · 2020-08-05FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for liraglutide. The approval updates the product's labeling/indicati…
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients [Phase 3]
Phase 3 trial evaluating a loose-dose combination of acarbose and metformin in type 2 diabetes patients failing metformin therapy.